Kyverna Therapeutics Congratulates Prof. G. Schett et al. on the Publication of a Case Series Follow-up of 15 Patients Living with Autoimmune Disease Treated With CAR T-Cell Therapy

/PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for...

Related Keywords

United States ,Germany ,Erlangen ,Bayern ,Georg Schett ,Peter Maag ,Prnewswire Kyverna Therapeutics Inc ,Erlangen Department Of Medicine ,Scientific Advisory Board ,New England Journal ,Media Contact ,